N/A
N=27
"Ounce-equivalents" in the Protein Foods Group: Benefits of Quality
Protein Metabolism
Bottom Line
View on ClinicalTrials.gov: NCT03179462 ↗Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Sep 2021
Primary outcome: Primary: Net Protein Synthesis Rate — 8.65; 1.97; 5.69 grams — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Pork intake (Dietary_supplement); Mixed nuts intake (Dietary_supplement); Tofu intake (Dietary_supplement)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Arkansas
- Primary completion
- Jun 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Net Protein Synthesis Rate |
8.65; 1.97; 5.69 | <0.05 sig |
Summary
The investigators will examine the effects of a given amount of a protein food source such as pork, mixed nuts, and tofu on anabolic response at the whole body and muscle levels in young, healthy adults.
Eligibility Criteria
Inclusion Criteria
- Men and women, ages 18-40 years
- BMI from 20 to 29.9 kg/m2
Exclusion Criteria
- Current diagnosis of diabetes
- History of malignancy in the 6 months prior to enrollment
- History of a chronic inflammatory condition or other chronic diseases (Lupus, HIV/AIDS, etc)
- History of weight reduction surgery (Lapband, gastric sleeve, etc.)
- Pregnant females
- Subjects who do not or will not eat animal proteins
- Subjects allergic to pork, tree or peanuts, or soybeans
- Subjects who cannot refrain from consuming protein or amino acid supplements during their participation in this study
- Subjects who report regular resistance training exercise > one per week
- Hemoglobin < 9.5 g/dL at the screening visit
- Platelets < 250, 000 at the screening visit
- Concomitant use of corticosteroids (ingestion, injection or transdermal)
- Any other disease or condition that would place the subject at increased risk of harm if they were to participate, at the discretion of the study physician
Data sourced from ClinicalTrials.gov (NCT03179462). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.